TrialAnaerobe2023

Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19.

Robert R Lavieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.